Ben Dunn and John Brooks III Join BioSurfaces Business Advisory Board

Release Date: April 8, 2022


BioSurfaces is pleased to announce Ben Dunn and John Brooks III have joined the company’s Business Advisory Board. Mr. Dunn and Mr. Brooks will provide expertise and guidance as BioSurfaces continues to advance its platform electrospinning technology (Bio-Spun™) in a number of industries, including medical devices, in vitro research tools, and consumer products.


Mr. Dunn is a Managing Director at Covington Associates, a Boston-based investment bank. For over 25 years he has been providing strategic advisory services to medical technology businesses and has orchestrated over 100 successful transactions. Mr. Dunn stated, “I’m excited to be working with the team at BioSurfaces. They have done an outstanding job of taking their expertise in electrospinning and turning it into a platform technology with a broad range of applications in the medical, biopharma and personal care markets.”


Mr. Brooks is a well-known life sciences executive, having co-founded eight life sciences companies including Insulet Corporation. Over his career, Mr. Brooks has served as a senior executive at Pfizer, a Senior Manager at Arthur Andersen, where he focused on early-stage companies, and CEO of Joslin Diabetes Center. Mr. Brooks stated, “I am truly excited to be working with the BioSurfaces team as they continue to demonstrate the broad capability of their Bio-Spun™ electrospinning technology. The level of strategic interest grows each day, as more and more life science companies see the superiority of the Bio-Spun™ platform.”


Matt Phaneuf, Co-Founder, President and CTO of BioSurfaces, commented, “We are excited that Ben and John have agreed to join our Business Advisory Board. They bring a high-level of experience that will be extremely valuable as we continue to grow BioSurfaces. We also expect to announce equally impressive additions to our Scientific Advisory Board over the next few months.”